Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 18/20 | 0.78 |
| ▸ | CNR1 | P21554 | 15/20 | 0.78 |
| ▸ | TP53 | P04637 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 1/20 | 0.77 |
| ▸ | MTOR | P42345 | 1/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.77 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8932684 | 0.91 | CNR2 (0.77) | CNR2CNR1TP53CYP3A4HPGD | |
| SCHEMBL9089051 | 0.89 | CNR2 (0.87) | CNR2CNR1TP53CYP3A4HPGD | |
| SCHEMBL29426346 | 0.88 | CNR2 (1.00) | CNR2CNR1TP53CYP3A4HPGD | |
| SCHEMBL29448220 | 0.87 | CNR2 (1.00) | CNR2CNR1TP53CYP3A4HPGD | |
| SCHEMBL29426317 | 0.87 | CNR2 (1.00) | CNR2CNR1TP53CYP3A4HPGD | |
| SCHEMBL430254 | 0.87 | CNR2 (1.00) | CNR2CNR1TP53CYP3A4HPGD | |
| SCHEMBL29835924 | 0.87 | CNR2 (1.00) | CNR2CNR1TP53CYP3A4HPGD | |
| SCHEMBL8932634 | 0.79 | CNR2 (0.88) | CNR2CNR1TP53CYP3A4HPGD | |
| SCHEMBL8932661 | 0.79 | CNR2 (1.00) | CNR2CNR1TP53CYP3A4HPGD | |
| SCHEMBL10068292 | 0.78 | CNR2 (0.85) | CNR2CNR1TP53CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5532237-A | INTRAOCULAR FOR TREATMENT OF GLAUCOMA | MERCK FROSST CANADA, INC. (CA) | 1996-07-02 | — | — | US | claimed |
| US-5532237-A | INTRAOCULAR FOR TREATMENT OF GLAUCOMA | MERCK FROSST CANADA, INC. (CA) | 1996-07-02 | — | — | US | disclosed |